Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | Karuna Therapeutics, Inc. KRTX | T. Rowe Price Investment Management Inc. | 2,709,629 7.200% | 2,709,629 (New Position) | Filing History |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | Karuna Therapeutics, Inc. KRTX | PRICE T ROWE ASSOCIATES INC | 1,963,957 5.200% | -399,347 (-16.90%) | Filing History |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | Karuna Therapeutics, Inc. KRTX | VANGUARD GROUP INC | 3,224,786 8.550% | 471,243 (+17.11%) | Filing History |
| 2024-02-12 12:25 pm Sale | 2024-02-12 | 13G | Karuna Therapeutics, Inc. KRTX | Capital International Investors | 448,866 1.200% | -3,865,518 (-89.60%) | Filing History |
| 2024-02-12 12:03 pm Sale | 2024-02-09 | 13G | Karuna Therapeutics, Inc. KRTX | FMR LLC | 858,944 2.276% | -2,007,050 (-70.03%) | Filing History |
| 2024-02-09 5:19 pm Purchase | 2024-02-07 | 13G | Karuna Therapeutics, Inc. KRTX | Capital International Investors | 4,314,384 11.400% | 475,644 (+12.39%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Karuna Therapeutics, Inc. KRTX | BlackRock Inc. BLK | 2,015,374 5.300% | 151,056 (+8.10%) | Filing History |
| 2024-01-10 08:53 am Sale | 2024-01-09 | 13G | Karuna Therapeutics, Inc. KRTX | FMR LLC | 2,865,994 7.596% | -2,286,995 (-44.38%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Karuna Therapeutics, Inc. KRTX | BlackRock Inc. BLK | 1,864,318 4.970% | -539,095 (-22.43%) | Filing History |
| 2023-06-20 8:56 pm Sale | 2023-06-14 | 13D | Karuna Therapeutics, Inc. KRTX | Sofinnova Venture Partners X L.P. | 1,439,649 3.800% | -386,975 (-21.19%) | Filing History |
| 2023-06-09 3:48 pm Purchase | 2023-06-12 | 13G | Karuna Therapeutics, Inc. KRTX | Capital International Investors | 3,838,740 10.300% | 3,838,740 (New Position) | Filing History |
| 2023-02-14 12:38 pm Purchase | 2022-12-31 | 13G | Karuna Therapeutics, Inc. KRTX | PRICE T ROWE ASSOCIATES INC | 2,363,304 6.900% | 407,938 (+20.86%) | Filing History |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | Karuna Therapeutics, Inc. KRTX | VANGUARD GROUP INC | 2,753,543 8.010% | 669,207 (+32.11%) | Filing History |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | Karuna Therapeutics, Inc. KRTX | FMR LLC | 5,152,989 14.995% | 578,883 (+12.66%) | Filing History |
| 2023-02-03 7:11 pm Purchase | 2023-01-12 | 13D | Karuna Therapeutics, Inc. KRTX | Sofinnova Venture Partners X L.P. | 1,826,624 5.300% | 97,272 (+5.62%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Karuna Therapeutics, Inc. KRTX | BlackRock Inc. BLK | 2,403,413 7.000% | 764,796 (+46.67%) | Filing History |
| 2022-09-20 4:58 pm Sale | 2022-08-12 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX, L.P. | 0 0.000% | -2,946,891 (Position Closed) | Filing History |
| 2022-08-12 4:31 pm Unchanged | 2022-08-12 | 13D | Karuna Therapeutics, Inc. KRTX | PureTech Health LLC | 1,531,564 4.600% | 0 (Unchanged) | Filing History |
| 2022-08-09 8:21 pm Sale | 2022-08-04 | 13D | Karuna Therapeutics, Inc. KRTX | PureTech Health LLC | 1,531,564 5.100% | -125,000 (-7.55%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Karuna Therapeutics, Inc. KRTX | PRICE T ROWE ASSOCIATES INC | 1,955,366 6.600% | 531,205 (+37.30%) | Filing History |